Roberta Terpin
Director/Board Member presso FRIULCHEM S.P.A.
Profilo
Roberta Terpin is currently a Director at Friulchem SpA, a Director at BMG Pharma SpA, an Investment Manager at Friulia SpA, and an Investment Committee Member at Bio4dreams SpA.
She was previously a Director at Pasta Zara SpA from 2015 to 2020.
Posizioni attive di Roberta Terpin
Società | Posizione | Inizio |
---|---|---|
FRIULCHEM S.P.A. | Director/Board Member | - |
Friulia SpA
Friulia SpA Investment ManagersFinance Friulia SpA is the private equity subsidiary of the Italian region of Friuli Venezia Giulia is founded in 1967. The firm headquartered in Trieste, Italy. | Private Equity Investor | 01/01/2008 |
Bio4dreams SpA
Bio4dreams SpA Investment ManagersFinance Bio4Dreams SpA (B4D) is a incubator firm. The firm was founded by Pietro Conti, Laura Iris Ferro, Elisabetta Borello and Cusi Daniele in 2017 and is headquartered in Bresso, Italy. | Private Equity Investor | 01/03/2020 |
BMG Pharma SpA
BMG Pharma SpA Household/Personal CareConsumer Non-Durables BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then. | Director/Board Member | 01/04/2021 |
Precedenti posizioni note di Roberta Terpin
Società | Posizione | Fine |
---|---|---|
Pasta Zara SpA
Pasta Zara SpA Food: Major DiversifiedConsumer Non-Durables Pasta Zara SpA manufactures and wholesales dry pasta. Its products include le fantasie, looney tunes, big shapes, whole-wheat, organic whole-wheat, le armonie, sublime, le magie, egg pasta, lasagne and cannelloni, cous cous, flours and le delizie. The company was founded by Emanuele Bragagnolo in 1898 and is headquartered in Riese Pio X, Italy. | Director/Board Member | 01/11/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
FRIULCHEM S.P.A. | Health Technology |
Aziende private | 4 |
---|---|
Friulia SpA
Friulia SpA Investment ManagersFinance Friulia SpA is the private equity subsidiary of the Italian region of Friuli Venezia Giulia is founded in 1967. The firm headquartered in Trieste, Italy. | Finance |
Pasta Zara SpA
Pasta Zara SpA Food: Major DiversifiedConsumer Non-Durables Pasta Zara SpA manufactures and wholesales dry pasta. Its products include le fantasie, looney tunes, big shapes, whole-wheat, organic whole-wheat, le armonie, sublime, le magie, egg pasta, lasagne and cannelloni, cous cous, flours and le delizie. The company was founded by Emanuele Bragagnolo in 1898 and is headquartered in Riese Pio X, Italy. | Consumer Non-Durables |
Bio4dreams SpA
Bio4dreams SpA Investment ManagersFinance Bio4Dreams SpA (B4D) is a incubator firm. The firm was founded by Pietro Conti, Laura Iris Ferro, Elisabetta Borello and Cusi Daniele in 2017 and is headquartered in Bresso, Italy. | Finance |
BMG Pharma SpA
BMG Pharma SpA Household/Personal CareConsumer Non-Durables BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then. | Consumer Non-Durables |
- Borsa valori
- Insiders
- Roberta Terpin